Meet us at the MetroFlow 2024 Annual Meeting.

Attend UCLA’s Shared Resources Day to learn how new tools can take your research to the next level!

Learn how Nanovials and help optimize cellular therapies.

Learn about linking cell secretions to their transcriptomes using SEC-seq.

“Lab on a particle” technologies, such as Nanovials, are emerging as an accessible platform for performing single-cell functional screening leveraging standard instrumentation, such as flow cytometers and microfluidic single-cell sequencing platforms. Learn about our progress in using Nanovial particles for discovery of monoclonal antibodies and the characterization and discovery of antigen-specific and metabolite-specific T cells.

“Lab on a particle” technologies, such as Nanovials, are emerging as an accessible platform for performing single-cell functional screening leveraging standard instrumentation, such as flow cytometers and microfluidic single-cell sequencing platforms. Learn about our progress in using Nanovial particles for discovery of monoclonal antibodies and the characterization and discovery of antigen-specific and metabolite-specific T cells.

Pairing Alloy Therapeutics’ best-in-class transgenic humanized mouse with Partillion Biosciences’ Nanovial technology provides a simple and cost-efficient method to perform high throughput screens of antibody secreting plasma cells for the discovery of antigen-specific antibodies. In this webinar, we demonstrate an antibody discovery workflow that yields diverse, high affinity binders with development potential in therapeutic settings.

By providing functional annotation in a high-throughput manner, Nanovials speed up the discovery of antibodies and cancer-specific TCRs, revolutionizing therapeutic antibody and T cell therapy development.

“Lab on a particle” technologies, such as Nanovials, are emerging as an accessible platform for performing single-cell functional screening leveraging standard instrumentation, such as flow cytometers and microfluidic single-cell sequencing platforms. Learn about our progress in using Nanovial particles for discovery of monoclonal antibodies and the characterization and discovery of antigen-specific and metabolite-specific T cells.

Come say hi at the Caltech Bioscience Industry Day, a flagship event of the Caltech Bioscience Industrial Partners Program (CBIPP), for a day of inspiring discussions, industry connections, and cutting-edge innovations in biodata, biopharma, biotech, life sciences, medical devices, and synthetic biology.

Don't miss our upcoming webinar to learn how to streamline your antibody discovery workflows.